Search in:

Expert Opinion on Drug Delivery Volume 17, 2020 - Issue 11

Submit an article Journal homepage

463

Views

CrossRef citations to date

Altmetric

Review

Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment

Anabel Sorollaa Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and Centre for Medical Research, The University of Western Australia, Crawley, AustraliaView further author information

Maria Alba Sorollab Biomedical Research Institute (IRB Lleida), Research Group of Cancer Biomarkers, Lleida, SpainView further author information

Edina Wanga Harry Perkins Institute of Medical Research, QEII Medical Centre, Nedlands and Centre for Medical Research, The University of Western Australia, Crawley, AustraliaView further author information

Valentín Ceñac Unidad Asociada Neurodeath, Universidad De Castilla-La Mancha, Albacete, Spain;d Centro De Investigación En Red Sobre Enfermedades Neurodegenerativas (CIBERNED), ISCIII, Madrid, SpainCorrespondence[email protected]

https://orcid.org/0000-0001-8928-3681 View further author information

Pages 1597-1613 | Received 27 Apr 2020, Accepted 21 Aug 2020, Published online: 11 Sep 2020

Cite this article
https://doi.org/10.1080/17425247.2020.1814733
CrossMark

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions

Citations (20)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Articles from other publishers (20)

Sanja M. Petrovic & Marcela-Elisabeta Barbinta-Patrascu. (2023) Organic and Biogenic Nanocarriers as Bio-Friendly Systems for Bioactive Compounds’ Delivery: State-of-the Art and Challenges. Materials 16:24, pages 7550.
Crossref

Zahid Delwar, Olga Tatsiy, Dmitry V. Chouljenko, I-Fang Lee, Guoyu Liu, Xiaohu Liu, Luke Bu, Jun Ding, Manu Singh, Yanal M. Murad & William Wei-Guo Jia. (2023) Prophylactic Vaccination and Intratumoral Boost with HER2-Expressing Oncolytic Herpes Simplex Virus Induces Robust and Persistent Immune Response against HER2-Positive Tumor Cells. Vaccines 11:12, pages 1805.
Crossref

Ali Akbar Ashkarran, Zijin Lin, Jatin Rana, Harvey Bumpers, Lorenzo Sempere & Morteza Mahmoudi. (2023) Impact of Nanomedicine in Women's Metastatic Breast Cancer. Small.
Crossref

Mayur Aalhate, Srushti Mahajan, Hoshiyar Singh, Santosh Kumar Guru & Pankaj Kumar Singh. (2023) Nanomedicine in therapeutic warfront against estrogen receptor–positive breast cancer. Drug Delivery and Translational Research 13:6, pages 1621-1653.
Crossref

Salma T. Rafik, Jayant S. Vaidya, Alexander J. MacRobert & Elnaz Yaghini. (2023) Organic Nanodelivery Systems as a New Platform in the Management of Breast Cancer: A Comprehensive Review from Preclinical to Clinical Studies. Journal of Clinical Medicine 12:7, pages 2648.
Crossref

Zhuo Peng, Keni Ning, Xiaoyan Tang, Ruikai He, Dong-Yang Zhang, Yan Ma, Shixia Guan & Junqiu Zhai. (2023) A multifunctional DNA repair enzyme and magnetic dual-triggered theranostic nanosystem for intelligent drug delivery. Materials & Design 226, pages 111611.
Crossref

Ling Li, Gregory J. Duns, Wubliker Dessie, Zhenmin Cao, Xiaoyuan Ji & Xiaofang Luo. (2023) Recent advances in peptide-based therapeutic strategies for breast cancer treatment. Frontiers in Pharmacology 14.
Crossref

Ülo LangelÜlo Langel. 2023. CPP, Cell-Penetrating Peptides. CPP, Cell-Penetrating Peptides 469 541 .

Weinan Li, HeXin Gong, Yuhan Fu, Jialin Sun & Yanhong Wang. (2022) Novel pH-sensitive nanoparticles based on prodrug strategy to delivery All-Trans Retinoic Acid for breast cancer. Colloids and Surfaces B: Biointerfaces 219, pages 112838.
Crossref

Liyun Niu, Huiyu Zhou, Yueru Lian, Ya Gao, Yulu Liu, Ruolan Gu, Zhuona Wu, Xiaoxia Zhu, Hui Gan, Zhiyun Meng & Guifang Dou. (2022) Evaluation of the metabolism of PEP06, an endostatin-RGDRGD 30-amino-acid polypeptide and a promising novel drug for targeting tumor cells. Journal of Pharmaceutical Analysis 12:5, pages 766-773.
Crossref

Polyxeni Nteli, Danae Efremia Bajwa, Dimitrios Politakis, Charalampos Michalopoulos, Anastasia Kefala-Narin, Efstathios P Efstathopoulos & Maria Gazouli. (2022) Nanomedicine approaches for treatment of hematologic and oncologic malignancies. World Journal of Clinical Oncology 13:7, pages 553-566.
Crossref

Poonam Banthia, Lokesh Gambhir, Asha Sharma, Dhiraj Daga, Neha Kapoor, Rishabh Chaudhary & Gaurav Sharma. (2022) Nano to rescue: repository of nanocarriers for targeted drug delivery to curb breast cancer. 3 Biotech 12:3.
Crossref

Ana Isabel Fraguas-Sánchez, Irene Lozza & Ana Isabel Torres-Suárez. (2022) Actively Targeted Nanomedicines in Breast Cancer: From Pre-Clinal Investigation to Clinic. Cancers 14:5, pages 1198.
Crossref

Sofia Teixeira, Maria Alice Carvalho & Elisabete M. S. Castanheira. (2022) Functionalized Liposome and Albumin-Based Systems as Carriers for Poorly Water-Soluble Anticancer Drugs: An Updated Review. Biomedicines 10:2, pages 486.
Crossref

Zicong You, Weijun Zhou, Junyan Weng, Haizhan Feng, Peiqiao Liang, Yuhua Li & Fujun Shi. (2021) Application of HER2 peptide vaccines in patients with breast cancer: a systematic review and meta-analysis. Cancer Cell International 21:1.
Crossref

Maria Alba Sorolla, Ivan Hidalgo, Anabel Sorolla, Robert Montal, Ona Pallisé, Antonieta Salud & Eva Parisi. (2021) Microenvironmental Reactive Oxygen Species in Colorectal Cancer: Involved Processes and Therapeutic Opportunities. Cancers 13:20, pages 5037.
Crossref

Salman Ahmed, Hamed Mirzaei, Michael Aschner, Ajmal Khan, Ahmed Al-Harrasi & Haroon Khan. (2021) Marine peptides in breast cancer: Therapeutic and mechanistic understanding. Biomedicine & Pharmacotherapy 142, pages 112038.
Crossref

Laura Marinela Ailioaie, Constantin Ailioaie & Gerhard Litscher. (2021) Latest Innovations and Nanotechnologies with Curcumin as a Nature-Inspired Photosensitizer Applied in the Photodynamic Therapy of Cancer. Pharmaceutics 13:10, pages 1562.
Crossref

Xue-Fang Lou, Yong-Zhong Du & Xiao-Ling Xu. (2021) Endogenous Enzyme-responsive Nanoplatforms for Anti-tumor Therapy. Current Drug Targets 22:8, pages 845-855.
Crossref

Samraggi Choudhury, Nidhi Aggarwal, Jiban Jyoti Panda & Jibanananda Mishra. 2021. Cancer Nanotheranostics. Cancer Nanotheranostics 161 187 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment

Articles from other publishers (20)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Peptides, proteins and nanotechnology: a promising synergy for breast cancer targeting and treatment

Citations (20)

Articles from other publishers (20)

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date